Nimesulide 200mg Tablet Franchise in Ahmedabad

Pain & Inflammation Relief Tablet Supplier in Mumbai

Nimoplit 200 Tablet Distributor in Delhi

NSAID Pain Management Tablet Franchise Opportunity in Bangalore

Musculoskeletal Pain Relief Tablet Stockist in Hyderabad
Nimesulide Export & Manufacturing in Chandigarh

Home/Products /nimesulide-200mg-tablet

Nimoplit 200 Tablet

Composition : Nimesulide (200mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

        Nimoplit 200 Tablet contains Nimesulide 200mg, a fast-acting non-steroidal anti-inflammatory drug indicated for the relief of acute pain, inflammation, and fever. It is commonly used in conditions such as musculoskeletal disorders, dental pain, post-surgical discomfort, and inflammatory conditions.

Nimesulide works by selectively inhibiting prostaglandin synthesis, thereby reducing inflammation and providing effective analgesic action. Its rapid onset helps improve patient comfort and mobility, making it suitable for short-term pain management.

For distributors and healthcare suppliers, Nimoplit 200 Tablet is a high-demand analgesic product, frequently prescribed by general physicians, orthopedic specialists, and dentists. The ongoing need for effective pain relief therapies ensures steady consumption across healthcare channels.

Adding Nimoplit 200 Tablet to your pain management and general medicine segment creates strong opportunities in retail pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven efficacy, broad therapeutic application, and strong prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

        Nimoplit 200 Tablet contains Nimesulide 200mg, a fast-acting non-steroidal anti-inflammatory drug indicated for the relief of acute pain, inflammation, and fever. It is commonly used in conditions such as musculoskeletal disorders, dental pain, post-surgical discomfort, and inflammatory conditions.

Nimesulide works by selectively inhibiting prostaglandin synthesis, thereby reducing inflammation and providing effective analgesic action. Its rapid onset helps improve patient comfort and mobility, making it suitable for short-term pain management.

For distributors and healthcare suppliers, Nimoplit 200 Tablet is a high-demand analgesic product, frequently prescribed by general physicians, orthopedic specialists, and dentists. The ongoing need for effective pain relief therapies ensures steady consumption across healthcare channels.

Adding Nimoplit 200 Tablet to your pain management and general medicine segment creates strong opportunities in retail pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven efficacy, broad therapeutic application, and strong prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, abdominal pain, heartburn, or diarrhea. Rare but serious side effects include liver toxicity, gastrointestinal bleeding, allergic reactions, or skin rashes. Medical attention is advised if symptoms such as jaundice, severe abdominal pain, or persistent nausea occur.

Nimoplit 200 Tablet is indicated for the management of acute pain, inflammatory conditions, musculoskeletal pain, dental pain, post-operative pain, and fever when other treatments are inadequate.

Nimoplit 200 Tablet should be used strictly as prescribed by a healthcare professional and is intended for short-term use only. Patients with liver disease, gastrointestinal ulcers, bleeding disorders, or hypersensitivity to NSAIDs should avoid this medicine. Alcohol consumption should be avoided during treatment.

Store Nimoplit 200 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and ensure the blister pack remains intact. Do not use the tablet after the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation